X4 Pharmaceuticals CEO René BCPS' 2018 pay jumps 188% to $3.4M
X4 Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: May 22, 2019
X4 Pharmaceuticals reported fiscal year 2018 executive compensation information on May 22, 2019.
In 2018, six executives at X4 Pharmaceuticals received on average a compensation package of $1.7M, a 109% increase compared to previous year.
Average pay of disclosed executives at X4 Pharmaceuticals
René Russo, Pharm.D., BCPS, Chief Executive Officer, received $3.4M in total, which increased by 188% compared to 2017. 57% of BCPS' compensation, or $1.9M, was in option awards. BCPS also received $406K in salary and $1M in other compensation.
Michael Gray, Chief Executive Officer, received a compensation package of $2.9M, which increased by 242% compared to previous year. 45% of the compensation package, or $1.3M, was in option awards.
Christopher Stevens, Chief Medical Officer, earned $1.3M in 2018, a 99% increase compared to previous year.
David Mantus, Former Chief Development Officer, received $1.1M in 2018, which increases by 149% compared to 2017.
Paula Ragan, Chief Executive Officer, earned $921K in 2018, a 22% increase compared to previous year.
Adam S. Mostafa, Chief Financial Officer, received $628K in 2018.
Related executives
Paula Ragan
X4 Pharmaceuticals
Chief Executive Officer
Adam Mostafa
X4 Pharmaceuticals
Chief Financial Officer
Michael Gray
X4 Pharmaceuticals
Chief Executive Officer
David Mantus
X4 Pharmaceuticals
Former Chief Development Officer
René BCPS
X4 Pharmaceuticals
Chief Executive Officer
Christopher Stevens
X4 Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on May 22, 2019.